Cargando…
Fenofibrate Nanocrystal Composite Microparticles for Intestine-Specific Oral Drug Delivery System
Hydrophobic drug nanocrystals (NCs) manufactured by particle engineering have been extensively investigated for enhanced oral bioavailability and therapeutic effectiveness. However, there are significant drawbacks, including fast dissolution of the nanocrystals in the gastric environment, leading to...
Autores principales: | Kevadiya, Bhavesh D., Chen, Liang, Zhang, Lu, Thomas, Midhun B., Davé, Rajesh N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789785/ https://www.ncbi.nlm.nih.gov/pubmed/31315263 http://dx.doi.org/10.3390/ph12030109 |
Ejemplares similares
-
Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement
por: Kevadiya, Bhavesh D., et al.
Publicado: (2018) -
In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate
por: Lin, You-Meei, et al.
Publicado: (2011) -
Aminoclay–lipid hybrid composite as a novel drug carrier of fenofibrate for the enhancement of drug release and oral absorption
por: Yang, Liang, et al.
Publicado: (2016) -
Synthesis of Saponite Based Nanocomposites to Improve the Controlled Oral Drug Release of Model Drug Quinine Hydrochloride Dihydrate
por: S., Kumaresan, et al.
Publicado: (2019) -
Efficacy of a micronized, nanocrystal fenofibrate formulation in treatment of hyperlipidemia in dogs
por: Munro, Matthew J. L., et al.
Publicado: (2021)